|
THE SENATE |
S.B. NO. |
3134 |
|
THIRTY-SECOND LEGISLATURE, 2024 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO THE TESTING OF CANNABIS AND MANUFACTURED CANNABIS PRODUCTS.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The
purpose of this Act is to require the office of medical cannabis control and
regulation of the department of health to implement a post-market testing
program to verify the labeling on cannabis and manufactured cannabis products
and monitor the shelf lives of cannabis and manufactured cannabis products.
SECTION 2.
Section 329D-8, Hawaii Revised Statutes, is amended by amending
subsection (a) to read as follows:
"(a)
The department shall establish and enforce standards for laboratory-based
testing of cannabis and manufactured cannabis products for content,
contamination, and consistency; provided that in establishing and enforcing
these standards, the department shall:
(1) Review and take guidance from the testing programs and standards utilized in other jurisdictions;
(2) Consider
the impact of the standards on the retail cost of the product to the qualifying
patient;
(3) Review
and take guidance from the testing programs and standards for
pesticides under the regulations of the United States Environmental Protection
Agency;
(4) Consider
processes that may allow cannabis or manufactured cannabis products that fail
testing standards to be remediated;
(5) For
the testing for microbiological impurities, consider the benefits of
organically grown cannabis that features the use of bacteria in lieu of
pesticides; [and]
(6) Include
permission for qualifying patients and primary caregivers to obtain testing
services directly from certified laboratories on the island where the
qualifying patient and primary caregiver reside[.]; and
(7) Purchase
cannabis and manufactured cannabis products from dispensaries randomly for the
purpose of conducting post-market testing of cannabis and manufactured cannabis
products. The testing shall be conducted
to:
(A) Verify labeling on cannabis and manufactured cannabis products; and
(B) Monitor the shelf lives of cannabis and manufactured cannabis
products."
SECTION 3. There is appropriated out of the medical cannabis registry and regulation special fund the sum of $__________ or so much thereof as may be necessary for fiscal year 2024-2025 for the implementation of the post-marketing testing program as required by this Act.
The sum appropriated shall be
expended by the department of health for the purposes of this Act.
SECTION 4.
Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 5. This Act, upon its approval, shall take effect on July 1, 2024.
|
INTRODUCED BY: |
_____________________________ |
|
|
BY REQUEST |
Report Title:
Department of Health; Cannabis and Manufactured Cannabis Products; Post-market Testing; Appropriation
Description:
Requires the Department of Health to implement a post-market testing program to verify the labeling on cannabis and manufactured cannabis products and monitor the shelf lives of cannabis and manufactured cannabis products.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.